Medicare Enrolled
Dr. Gerardo Bueso, MD
Endocrinology · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bueso from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bueso?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bueso
Dr. Gerardo Bueso is an endocrinology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bueso performed 11,100 Medicare services across 4,043 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bueso received a total of $21,639 from 77 pharmaceutical and/or device companies across 1318 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bueso is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in TX
$21,639 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,100
Medicare services
Top 5% in TX for endocrinology
4,043
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~584 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Online digital E/M service, established patient, 21+ minutes An online digital evaluation and management service for an established patient. This service requires a total time of 21 or more minutes over a period of up to 7 days. |
1,796 | $37 | $60 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,387 | $61 | $125 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
1,159 | $3 | $20 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
778 | $63 | $100 |
| Online digital E/M service, established patient, 11-20 min An online digital evaluation and management service for an established patient. The service involves a total time of 11 to 20 minutes over a period of up to 7 days. |
776 | $23 | $40 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
723 | $10 | $50 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
643 | $39 | $60 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
496 | $39 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
374 | $92 | $175 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
302 | $21 | $150 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
232 | $2 | $20 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
230 | $9 | $65 |
| Online digital evaluation for established patient, 5-10 minutes This service involves an online digital evaluation and management visit for an established patient. It covers a total time of 5 to 10 minutes over a period of up to 7 days. |
229 | $11 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
225 | $131 | $180 |
| Annual depression screening | 218 | $19 | $50 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
171 | $66 | $300 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
171 | $32 | $50 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
169 | $71 | $200 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
168 | $81 | $300 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
155 | $31 | $75 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
149 | $26 | $60 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
63 | $133 | $225 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
60 | $10 | $60 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
60 | $41 | $100 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
52 | $6 | $25 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
51 | $5 | $75 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
37 | $98 | $400 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
37 | $107 | $315 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
32 | $29 | $118 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
28 | $14 | $25 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $93 | $130 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
26 | $84 | $150 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
22 | $167 | $180 |
| X-ray of middle spine, 2 views An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints. |
21 | $24 | $116 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
20 | $33 | $101 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $125 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$21,639
Total received (2018-2024)
Avg $3,091/year across 7 years
Top 21% in TX for endocrinology
77
Companies
1,318
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,487 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$152 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,681
2023
$2,945
2022
$3,969
2021
$3,252
2020
$2,505
2019
$2,648
2018
$3,638
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$2,262
Abbott Laboratories
$1,927
Amgen Inc.
$1,035
Amarin Pharma Inc.
$990
Boehringer Ingelheim Pharmaceuticals, Inc.
$978
Lilly USA, LLC
$897
SANOFI-AVENTIS U.S. LLC
$881
AstraZeneca Pharmaceuticals LP
$839
Zealand Pharma US, Inc.
$760
Mannkind Corporation
$638
MannKind Corporation
$574
Regeneron Healthcare Solutions, Inc.
$556
Bayer HealthCare Pharmaceuticals Inc.
$489
Corcept Therapeutics
$484
Dexcom, Inc.
$426
Horizon Therapeutics plc
$418
Janssen Pharmaceuticals, Inc
$405
Valeritas, Inc.
$403
Merck Sharp & Dohme Corporation
$390
Medtronic, Inc.
$384
Xeris Pharmaceuticals, Inc.
$343
Medtronic MiniMed, Inc.
$340
AbbVie Inc.
$329
Esperion Therapeutics, Inc.
$315
RECORDATI_RARE_DISEASES_INC.
$303
Novartis Pharmaceuticals Corporation
$290
AbbVie, Inc.
$258
Takeda Pharmaceuticals U.S.A., Inc.
$222
Bayer Healthcare Pharmaceuticals Inc.
$203
CeQur Corporation
$177
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$172
Becton, Dickinson and Company
$168
Amneal Pharmaceuticals LLC
$156
Allergan, Inc.
$150
Insulet Corporation
$147
Allergan Inc.
$138
DEXCOM, INC.
$130
Exact Sciences Corporation
$123
Ipsen Biopharmaceuticals, Inc
$110
Antares Pharma, Inc.
$110
Astellas Pharma US Inc
$106
VIVUS LLC
$97
IBSA Pharma Inc.
$94
OPKO Pharmaceuticals, LLC
$86
PFIZER INC.
$86
Shire North American Group Inc
$82
Intuity Medical Inc
$82
Alexion Pharmaceuticals, Inc.
$78
ARBOR PHARMACEUTICALS, INC.
$77
Eisai Inc.
$69
ABBVIE INC.
$66
EUSA Pharma (US) LLC
$60
Amryt Pharma Holdings Ltd
$57
Radius Health, Inc.
$51
VIVUS, Inc.
$49
LifeScan, Inc.
$48
BETA BIONICS, INC.
$48
Kyowa Kirin, Inc.
$47
Strongbridge US INC.
$46
Synergy Pharmaceuticals Inc
$40
Horizon Pharma plc
$39
Gilead Sciences, Inc.
$37
Ascendis Pharma Inc
$34
Tandem Diabetes Care, Inc.
$33
KVK-Tech, Inc.
$27
EISAI INC.
$26
Arbor Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme LLC
$17
Tolmar, Inc.
$15
Aytu BioScience, Inc
$15
Medtronic Vascular, Inc.
$14
West-Ward Pharmaceuticals
$14
Endo Pharmaceuticals Inc.
$14
GlaxoSmithKline, LLC.
$12
Ironwood Pharmaceuticals, Inc
$12
Currax Pharmaceuticals LLC
$11
EMD Serono, Inc.
$11
Top 3 companies account for 24.1% of total payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Androgel · Assurity Pacemaker · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYSTOLIC · Belviq · Bidil · CAPVAXIVE · CHANTIX · CONTRAVE · CYCLOSET · CeQur Simplicity · ClosureFast · Cologuard Collection Kit · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIAMONDBACK PERIPHERAL · DUEXIS · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Edarbi · Edarbyclor · Enlite Sensor · Epclusa · FARXIGA · FORTEO · FREESTYLE LIBRE · FreeStyle Libre · FreeStyle Libre Pro · GALLANT · GATTEX · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · Horizant · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKAMET · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · LEQVIO · LINZESS · LOKELMA · LYRICA · MACRILEN · MINIMED 780G · MOUNJARO · MOVANTIK · MYCAPSSA · MYRBETRIQ · Macrilen · Minimed 530G · Minimed 670G System · Mitigare · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NOCDURNA · Natesto · Norditropin · OT Verio Flex Starter Kit · OTREXUP · Omnipod · OneTouch · Ozempic · PENNSAID · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · Pogo Automatic Blood Glucose Monitoring System · Proclaim Family of SCS IPGs · Prolia · QSYMIA · QUADRA ASSURA · Qsymia · RAYOS · RECORLEV · RYBELSUS · Rayaldee · Repatha · Rybelsus · SEROSTIM · SHINGRIX · SIGNIFOR LAR · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · STEGLATRO · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Trulance · Tymlos · UBRELVY · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VIBERZI · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $195 per 100 Medicare services performed
Geographic Context
Endocrinologists within 10 mi
147
Per 100K population
3.1
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bueso is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bueso experienced with online digital e/m service, established patient, 21+ minutes?
Based on Medicare claims data, Dr. Bueso performed 1,796 online digital e/m service, established patient, 21+ minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bueso receive payments from pharmaceutical companies?
Yes. Dr. Bueso received a total of $21,639 from 77 companies across 1,318 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bueso's costs compare to other endocrinologists in Houston?
Dr. Bueso's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bueso) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Houston
Browse endocrinologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in TX
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in TX
Which TX endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology